Matthew Walton

11PUBLICATIONS
31CO-AUTHORS
Major global burdens of diseaseCancer diagnosisMedical molecular engineering of nucleic acids and proteinsVision scienceDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 16, 2026
Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis.

Mark Corbett, Chinyereugo Umemneku-Chikere, Sarah Nevitt

|Feb 09, 2026
Artificial Intelligence technologies for assessing skin lesions for referral on the urgent suspected cancer pathway to detect benign lesions and reduce secondary care specialist appointments: early value assessment.

Matthew Walton, Alexis Llewellyn, Eleonora Uphoff

|Nov 03, 2025
Re-anchoring the Value of Innovative Therapies in NICE Decision Making When Comparators are Cost Ineffective: A Case Study of Late-Onset Pompe Disease.

Matthew Walton, Nyanar J Deng, Mark Corbett

|May 10, 2025
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and economic analysis.

Mark Simmonds, Matthew Walton, Rob Hodgson

|Apr 05, 2025
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.

Mark Simmonds, Alexis Llewellyn, Ruth Walker

|Jan 30, 2025
A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy.

Robert Hodgson, Matthew Walton, Helen Fulbright

Pageof 2

Frequent Collaborators

8 joint publications

Robert Hodgson

6 joint publications

Helen Fulbright

5 joint publications

Alexis Llewellyn

5 joint publications

Sofia Dias